WO2017035176A8 - Method of preventing or treating obesity with an emc10 inhibitor - Google Patents

Method of preventing or treating obesity with an emc10 inhibitor Download PDF

Info

Publication number
WO2017035176A8
WO2017035176A8 PCT/US2016/048271 US2016048271W WO2017035176A8 WO 2017035176 A8 WO2017035176 A8 WO 2017035176A8 US 2016048271 W US2016048271 W US 2016048271W WO 2017035176 A8 WO2017035176 A8 WO 2017035176A8
Authority
WO
WIPO (PCT)
Prior art keywords
emc10
preventing
inhibitor
treating obesity
obesity
Prior art date
Application number
PCT/US2016/048271
Other languages
French (fr)
Other versions
WO2017035176A1 (en
Inventor
Chong Wee LIEW
Xuanchun WANG
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of WO2017035176A1 publication Critical patent/WO2017035176A1/en
Publication of WO2017035176A8 publication Critical patent/WO2017035176A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compositions and methods for inhibiting Emc10 expressing or activity and preventing, treating, or delaying the onset of metabolic diseases such obesity are described.
PCT/US2016/048271 2015-08-24 2016-08-24 Method of preventing or treating obesity with an emc10 inhibitor WO2017035176A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562209108P 2015-08-24 2015-08-24
US62/209,108 2015-08-24

Publications (2)

Publication Number Publication Date
WO2017035176A1 WO2017035176A1 (en) 2017-03-02
WO2017035176A8 true WO2017035176A8 (en) 2017-05-04

Family

ID=56889209

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/048271 WO2017035176A1 (en) 2015-08-24 2016-08-24 Method of preventing or treating obesity with an emc10 inhibitor

Country Status (1)

Country Link
WO (1) WO2017035176A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107998397B (en) * 2017-12-07 2020-09-04 复旦大学附属华山医院 Application of EMC10 protein as biomarker in diagnosis of male infertility
CN108845142A (en) * 2018-06-19 2018-11-20 上海伦泽生物科技有限公司 Application of the EMC10 Protein Detection object in the diagnosis of preparation obesity and scale evaluation and Bariatric effect assessment product
CN114149499B (en) * 2020-09-07 2023-12-05 复旦大学附属华山医院 Monoclonal antibodies against human EMC10 and their use in the treatment and/or prevention of obesity
CN114149500B (en) * 2020-09-07 2023-12-01 复旦大学附属华山医院 Application of monoclonal antibody against human EMC10 in preparation of products for treating and/or preventing fatty liver
WO2022048577A1 (en) * 2020-09-07 2022-03-10 复旦大学附属华山医院 Use of monoclonal antibody against human emc10 in preparation of products for preventing and/or treating metabolic diseases
CN114149498B (en) * 2020-09-07 2023-12-05 复旦大学附属华山医院 Application of monoclonal antibody against human EMC10 in preventing and treating type 2 diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101985475A (en) * 2009-07-28 2011-03-16 复旦大学附属华山医院 Novel polyclonal antibody of secretive peptide INM02 and preparation method and use thereof
EP2726108B1 (en) * 2011-06-29 2018-01-10 The Trustees of Columbia University in the City of New York Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction

Also Published As

Publication number Publication date
WO2017035176A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
EP4253412A3 (en) Inhibition of cytokine-induced sh2 protein in nk cells
EP3634424A4 (en) Compositions and methods for preventing or treating muscle conditions
WO2017035176A8 (en) Method of preventing or treating obesity with an emc10 inhibitor
WO2016168592A3 (en) Compositions for modulating c9orf72 expression
EP3634442A4 (en) Methods for treating and preventing diseases
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
EP3576776A4 (en) Compositions and methods for treating heart failure
EP3207940A4 (en) Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
SG11201705450SA (en) Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
EP3538189A4 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
EP3294761A4 (en) Compositions and methods for treatment and prevention of uropathogenice. coli
MX2022007436A (en) Autotaxin inhibitors and uses thereof.
EP3775263A4 (en) Compositions and methods for the treatment of acne
EP3589283A4 (en) Method and composition for treating eating disorders
EP3609525A4 (en) Compositions and methods for treating or preventing gut permeability-related disorders
EP3720421A4 (en) Compositions and methods for the treatment of metabolic conditions
EP3801478A4 (en) Methods and compositions for preventing or treating calciphylaxis
EP3818085A4 (en) Compositions and uses thereof for treating disease or condition
EP3737379A4 (en) Compositions and methods for treating metabolic diseases
EP3595689A4 (en) Methods and compositions for treating obesity, inflammation, or metabolic disorders with bacteriophages
EP3359178A4 (en) Methods and compositions for unwanted or abnormal muscle contractions
EP3801620A4 (en) Compositions and methods for treating pancreatitis
WO2017019951A3 (en) Compositions amd methods of treating acne and photoaging
EP3596082A4 (en) Cdpk1 inhibitors, compositions and methods related thereto
EP3426256A4 (en) Methods of treating or reducing the risk of cardiovascular events and related diseases using sglt-2 inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16763133

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16763133

Country of ref document: EP

Kind code of ref document: A1